Hande KR - Search Results

1

Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small cell lung cancer.

Johnson DH, Strupp J, Greco FA, Stewart J, Merrill W, Malcolm A, Hande KR, Hainsworth JD. Johnson DH, et al. Among authors: hande kr. Cancer. 1991 Sep 15;68(6):1216-20. doi: 10.1002/1097-0142(19910915)68:6<1216::aid-cncr2820680606>3.0.co;2-g. Cancer. 1991. PMID: 1651802

2

Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study.

Thompson DS, Hainsworth JD, Hande KR, Holzmer M, Greco FA. Thompson DS, et al. Among authors: hande kr. Cancer. 1994 Jun 1;73(11):2824-31. doi: 10.1002/1097-0142(19940601)73:11<2824::aid-cncr2820731127>3.0.co;2-t. Cancer. 1994. PMID: 8194024 Clinical Trial.

3

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

Johnson DH, Paul DM, Hande KR, Shyr Y, Blanke C, Murphy B, Lewis M, De Vore RF 3rd. Johnson DH, et al. Among authors: hande kr. J Clin Oncol. 1996 Jul;14(7):2054-60. doi: 10.1200/JCO.1996.14.7.2054. J Clin Oncol. 1996. PMID: 8683236 Clinical Trial.

4

Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).

Johnson DH, Paul DM, Hande KR, DeVore R. Johnson DH, et al. Among authors: hande kr. Semin Oncol. 1996 Dec;23(6 Suppl 16):42-6. Semin Oncol. 1996. PMID: 9007120 Clinical Trial.

5

A randomized Phase II trial in patients with carcinoma of an unknown primary site.

Dowell JE, Garrett AM, Shyr Y, Johnson DH, Hande KR. Dowell JE, et al. Among authors: hande kr. Cancer. 2001 Feb 1;91(3):592-7. doi: 10.1002/1097-0142(20010201)91:3<592::aid-cncr1039>3.0.co;2-5. Cancer. 2001. PMID: 11169943 Clinical Trial.

6

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.

Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr Y, Johnson DH. Choy H, et al. Among authors: hande kr. Lung Cancer. 2001 Dec;34(3):441-9. doi: 10.1016/s0169-5002(01)00279-3. Lung Cancer. 2001. PMID: 11714542 Clinical Trial.

7

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer.

Murphy PB, Hainsworth JD, Greco FA, Hande KR, DeVore RF, Johnson DH. Murphy PB, et al. Among authors: hande kr. Cancer. 1992 Jan 15;69(2):370-5. doi: 10.1002/1097-0142(19920115)69:2<370::aid-cncr2820690217>3.0.co;2-e. Cancer. 1992. PMID: 1309432 Clinical Trial.

8

Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.

Waits TM, Johnson DH, Hainsworth JD, Hande KR, Thomas M, Greco FA. Waits TM, et al. Among authors: hande kr. J Clin Oncol. 1992 Feb;10(2):292-6. doi: 10.1200/JCO.1992.10.2.292. J Clin Oncol. 1992. PMID: 1310104 Clinical Trial.

9

Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.

Greco FA, Murphy PB, Hainsworth JD, Hande KR, Johnson DH. Greco FA, et al. Among authors: hande kr. Oncology. 1992;49 Suppl 1:34-8; discussion 39. doi: 10.1159/000227108. Oncology. 1992. PMID: 1323810 Clinical Trial.

10

Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

Johnson DH, Hainsworth JD, DeVore R, Hande KR, Greco FA. Johnson DH, et al. Among authors: hande kr. Oncology. 1992;49 Suppl 1:57-61; discussion 61-2. doi: 10.1159/000227112. Oncology. 1992. PMID: 1323813 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters